Novel compounds as dipeptidyl peptidase IV (dpp iv) inhibitors

Sudershan Arora (Uitvinder), Neelima Sinha (Uitvinder), Prathap Nair (Uitvinder), Sai Kumar Chakka (Uitvinder), Anil Hajare (Uitvinder), Azmi Reddy (Uitvinder), Pravin Patil (Uitvinder), Majid Sayyed (Uitvinder), Rajender Kumar Kamboj (Uitvinder), K.H. Sreedhara Swamy (Uitvinder), Rajan Goel (Uitvinder)


5 Downloads (Pure)


The present invention is related to novel compounds of the general formula (A), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved.
Originele taal-2English
StatusPublished - 26-mrt-2009

Citeer dit